Sequenom, Inc. Announces Participation At The 2014 Wedbush Securities Life Sciences Management Access Conference

  Sequenom, Inc. Announces Participation At The 2014 Wedbush Securities Life
                    Sciences Management Access Conference

PR Newswire

SAN DIEGO, Aug. 5, 2014

SAN DIEGO, Aug. 5, 2014 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative genetic analysis solutions, today
announced the Company's participation at the 2014 Wedbush Securities Life
Sciences Management Access Conference at Le Parker Meridien in New York, NY on
August 12-13, 2014.

William Welch, President and Chief Operating Officer, will present on Tuesday,
August 12, beginning at 4:15 p.m. ET to provide an overview of and update on
the Company. The presentation is expected to last approximately 30 minutes and
will be webcast live through the "Invest" section of the Sequenom Web site at
www.sequenom.com. An audio replay will be available for 30 days following the
initial broadcast.

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving health care through revolutionary genomic and genetic analysis
solutions. Sequenom develops innovative technologies, products, and diagnostic
tests that target and serve molecular diagnostic markets. Web site:
www.sequenom.com

SEQUENOM logo.

Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO

SOURCE Sequenom, Inc.

Website: http://www.sequenom.com
Contact: Carolyn Beaver, Chief Financial Officer, Sequenom, Inc.,
858-202-9028, investorrelations@sequenom.com or Rachel Kennedy, Media Contact,
Chandler Chicco Agency, 858-449-9575, rkennedy@chandlerchiccocompanies.com
 
Press spacebar to pause and continue. Press esc to stop.